regorafenib

Bayer, Onyx Win U.S. Approval for Colorectal Cancer Treatment

Bayer, Onyx Win U.S. Approval for Colorectal Cancer Treatment

Bloomberg

Priority Review for Bayer/Onyx

Priority Review for Bayer/Onyx

Yahoo/Zacks

[video] Onyx Pharma CEO on New Cancer Drug

[video] Onyx Pharma CEO on New Cancer Drug

CNBC

Onyx Pharma: Phase 3 trial of Regorafenib meets primary endpoint for GIST

Onyx Pharma: Phase 3 trial of Regorafenib meets primary endpoint for GIST

Yahoo/Fly on the Wall

Bayer Says Drug Held Off Gastrointestinal Tumors in Study

Bayer Says Drug Held Off Gastrointestinal Tumors in Study

Bloomberg

2 High-Flying Biotechs Face a New Hurdle

2 High-Flying Biotechs Face a New Hurdle

Motley Fool

Onyx Colon Cancer Drug Juggles Survival Benefit With Serious Side Effects

Onyx Colon Cancer Drug Juggles Survival Benefit With Serious Side Effects

TheStreet.com

Onyx put selling hinges on time decay

Onyx put selling hinges on time decay

Yahoo/optionMONSTER